The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Maintaining Cell Identity through Global Control of Genomic Organization
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“…that genes retain a memory of their functional state, has been translated into precise molecular mechanisms after the realization that chromatin is a moldable template subject to modifications that alter the accessibility and function of the underlying genetic material (Jenuwein and Allis, 2001).”
BackgroundHigh-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 4×
“Moreover, every TF has an intrinsic affinity for DNA (irrespective of its sequence) that, although orders of magnitudes lower than the affinity for specific sites, may account for nonspecific binding events detected by ChIP-Seq.”
MethodInfluentialA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 1×
“Irrespective of their location relative to coding units, transcriptional enhancers are defined by a simple but apparently specific chromatin signature that consists of high amounts of H3K4me1 and low or undetectable H3K4me3 (H3K4me1hi/H3K4me3lo domains) (Heintzman et al., 2007, 2009).”
BackgroundBird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., et al. (2009) · Nature · doi:10.1038/nature07829 · Cited by 2,533 · cited 5×
“Most importantly, enhancers are at least to a large extent cell type specific (Heintzman et al., 2009; Heinz et al., 2010), meaning that the genomic regions that are used as enhancers are different in different cell types (Figure 1).”
BackgroundInfluentialGenomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 1×
“…to daughter chromatin fibers is that of DNA methylation, which requires the activity of a maintenance DNA methyltransferase (Dnmt1) as well as of two other enzymes (Dnmt3a and Dnmt3b) that were erroneously considered to be selectively involved in de novo DNA methylation (Klose and Bird, 2006).”
Background
Cited by
DNA methylation arrays as surrogate measures of cell mixture distribution
Houseman, E. A., Accomando, W. P., Koestler, D. C., Christensen, B. C., Marsit, C. J., Nelson, H. H., Wiencke, J. K., & Kelsey, K. T. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-86 · Cited by 3,175
“One such epigenetic mark is DNA methylation, which is tightly associated with alterations in the nucleosome DNA scaffold (and hence chromatin) that is responsible for coordination of gene expression in individual cells [1-3].”
BackgroundTranscriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
Self-citationDiversity, Mechanisms, and Significance of Macrophage Plasticity
Locati, M., Curtale, G., & Mantovani, A. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012718 · Cited by 2,199
Latent Enhancers Activated by Stimulation in Differentiated Cells
Ostuni, R., Piccolo, V., Barozzi, I., Polletti, S., Termanini, A., Bonifacio, S., Curina, A., Prosperini, E., Ghisletti, S., & Natoli, G. (2013) · Cell · doi:10.1016/j.cell.2012.12.018 · Cited by 867
Self-citationMechanisms of Jak/STAT Signaling in Immunity and Disease
Villarino, A. V., Kanno, Y., Ferdinand, J. R., & O’Shea, J. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401867 · Cited by 552
Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification
Samstein, R. M., Arvey, A., Josefowicz, S. Z., Peng, X., Reynolds, A., Sandstrom, R., Neph, S., Sabo, P., Kim, J. M., Liao, W., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.053 · Cited by 472
Reference-free cell mixture adjustments in analysis of DNA methylation data
Houseman, E. A., Molitor, J., & Marsit, C. J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu029 · Cited by 441
“However, these adjustments require the existence of reference datasets, which may be laborious or expensive to collect.”
BackgroundNoncoding Transcription at Enhancers: General Principles and Functional Models
Natoli, G., & Andrau, J.-C. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155459 · Cited by 403
Self-citationEpigenetic regulation of macrophage polarization and function
Ivashkiv, L. B. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.11.001 · Cited by 396
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Zhang, H., Liu, L., Liu, J., Dang, P., Hu, S., Yuan, W., Sun, Z., Liu, Y., & Wang, C. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01725-x · Cited by 389
STATs Shape the Active Enhancer Landscape of T Cell Populations
Vahedi, G., Takahashi, H., Nakayamada, S., Sun, H.-W., Sartorelli, V., Kanno, Y., & O’Shea, J. J. (2012) · Cell · doi:10.1016/j.cell.2012.09.044 · Cited by 367
H3K4 tri‐methylation provides an epigenetic signature of active enhancers
Pekowska, A., Benoukraf, T., Zacarias‐Cabeza, J., Belhocine, M., Koch, F., Holota, H., Imbert, J., Andrau, J., Ferrier, P., & Spicuglia, S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.295 · Cited by 362
Kanno, Y., Vahedi, G., Hirahara, K., Singleton, K., & O'Shea, J. J. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075058 · Cited by 342
“Until recently, evidence of enhancer function relied primarily on conservation (and therefore denoted conserved noncoding sequences or CNS) and DNase hypersensitivity sites (116, 117).”
BackgroundZhang, J. A., Mortazavi, A., Williams, B. A., Wold, B. J., & Rothenberg, E. V. (2012) · Cell · doi:10.1016/j.cell.2012.01.056 · Cited by 337
“…e.g., The specific cis-regulatory elements affected by changing transcription factor action during commitment should be sites of developmentally changing histone modifications (reviewed by Natoli, 2010; Kouzarides, 2007), of greatest interest where they are linked to differentially expressed genes.”
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
Mullican, S. E., Gaddis, C. A., Alenghat, T., Nair, M. G., Giacomin, P. R., Everett, L. J., Feng, D., Steger, D. J., Schug, J., Artis, D., et al. (2011) · Genes & Development · doi:10.1101/gad.175950.111 · Cited by 314
“1, which is the major determinant of the macrophage epigenome (Ghisletti et al. 2010; Heinz et al. 2010; Natoli 2010; Natoli et al. 2011).”
BackgroundGenomic views of STAT function in CD4+ T helper cell differentiation
O'Shea, J. J., Lahesmaa, R., Vahedi, G., Laurence, A., & Kanno, Y. (2011) · Nature Reviews Immunology · doi:10.1038/nri2958 · Cited by 295
Blecher-Gonen, R., Barnett-Itzhaki, Z., Jaitin, D., Amann-Zalcenstein, D., Lara-Astiaso, D., & Amit, I. (2013) · Nature Protocols · doi:10.1038/nprot.2013.023 · Cited by 292
Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells
Soucie, E. L., Weng, Z., Geirsdóttir, L., Molawi, K., Maurizio, J., Fenouil, R., Mossadegh-Keller, N., Gimenez, G., VanHille, L., Beniazza, M., et al. (2016) · Science · doi:10.1126/science.aad5510 · Cited by 263
Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
Cheng, H., Wang, Z., Fu, L., & Xu, T. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00421 · Cited by 265
Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
Van Wyngene, L., Vandewalle, J., & Libert, C. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708712 · Cited by 263
Direct lineage conversions: unnatural but useful?
Vierbuchen, T., & Wernig, M. (2011) · Nature Biotechnology · doi:10.1038/nbt.1946 · Cited by 259
Barozzi, I., Simonatto, M., Bonifacio, S., Yang, L., Rohs, R., Ghisletti, S., & Natoli, G. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.006 · Cited by 209
Self-citationKang, K., Park, S. H., Chen, J., Qiao, Y., Giannopoulou, E., Berg, K., Hanidu, A., Li, J., Nabozny, G., Kang, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.017 · Cited by 196
“…transcription factors (LDTFs) PU.1 and C/EBP, which open chromatin at enhancer sites (Ghisletti Immunity 47, 235–250, August 15, 2017 ª 2017 Elsevier Inc. 235 (legend continued on next page) 236 Immunity 47, 235–250, August 15, 2017 et al., 2010; Glass andNatoli, 2016; Natoli, 2010).”
Mulder, R. H., Neumann, A., Cecil, C. A. M., Walton, E., Houtepen, L. C., Simpkin, A. J., Rijlaarsdam, J., Heijmans, B. T., Gaunt, T. R., Felix, J. F., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddaa280 · Cited by 165
High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq
Vanhille, L., Griffon, A., Maqbool, M. A., Zacarias-Cabeza, J., Dao, L. T. M., Fernandez, N., Ballester, B., Andrau, J. C., & Spicuglia, S. (2015) · Nature Communications · doi:10.1038/ncomms7905 · Cited by 158
The genomic landscapes of inflammation
Natoli, G., Ghisletti, S., & Barozzi, I. (2011) · Genes & Development · doi:10.1101/gad.2018811 · Cited by 152
Self-citationBunting, K. L., Soong, T. D., Singh, R., Jiang, Y., Béguelin, W., Poloway, D. W., Swed, B. L., Hatzi, K., Reisacher, W., Teater, M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.012 · Cited by 141
Andersson, R. (2015) · BioEssays · doi:10.1002/bies.201400162 · Cited by 127
Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1
Pham, T.-H., Minderjahn, J., Schmidl, C., Hoffmeister, H., Schmidhofer, S., Chen, W., Längst, G., Benner, C., & Rehli, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt355 · Cited by 102
Duel of the fates: the role of transcriptional circuits and noise in CD4+ cells
Hebenstreit, D., Deonarine, A., Babu, M. M., & Teichmann, S. A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.03.007 · Cited by 20
Epidermal stem cells: an update on their potential in regenerative medicine
Sun, X., Fu, X., Han, W., Zhao, M., & Chalmers, L. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.776036 · Cited by 10
Metadata
- Authors
- Natoli, G.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 33
- Issue
- 1
- Pages
- 12-24
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W1980779363
- Cited by
- 201
- References
- 32
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.